18.02.2015 • News

Arkema’s Option to Lift Share of Chinese Firm Extended

Arkema has extended until January 2016 its call option to increase its share in Sunke, the acrylics joint venture with Jurong Chemical in China.

Exercising the option would give the French chemical producer the third of the jv it does not yet own. Under the terms of the agreement signed in January 2014, Arkema was initially expected to exercise of this option during the first quarter 2015.

With the full takeover of the company established in 2014, Arkema would have access to its 320,000 t/year acrylic acid production capacity.

The manufacturing joint venture owns and operates acrylic acid and butyl acrylate productions lines in the People's Republic's Taixing, Jiangsu Province.

Financial terms of the initial agreement signed in January 2014 have been adjusted to reflect the extension of the option, and all conditions remain unchanged, the jv partners said.

Arkema's final option to acquire the remaining share capital remains unchanged and can be exercised until early 2020.

In the interim, the acrylics producer will be jointly operated by the two companies, and production levels will be adjusted to market conditions.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read